We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
-5.06%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$48.4B
AUM Growth
-$3.14B
Cap. Flow
-$231M
Cap. Flow %
-0.48%
Top 10 Hldgs %
30.2%
Holding
4,340
New
176
Increased
1,269
Reduced
1,824
Closed
174

Sector Composition

Rank Sector Weight
1 Technology 11.43%
2 Healthcare 8.99%
3 Financials 7.75%
4 Industrials 6.06%
5 Consumer Staples 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SP
3976
DELISTED
SP Plus Corporation
SP
$1K ﹤0.01%
19
AFIB
3977
DELISTED
Acutus Medical Inc
AFIB
$1K ﹤0.01%
1,000
VIEW
3978
DELISTED
View, Inc. Class A Common Stock
VIEW
$1K ﹤0.01%
13
NEPT
3979
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$1K ﹤0.01%
+18
New +$1.23K
BFX
3980
DELISTED
BowFlex Inc.
BFX
$1K ﹤0.01%
616
-1,995
-76% -$4.02K
RPT
3981
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$1K ﹤0.01%
161
-10
-6% -$98
CWBR
3982
DELISTED
CohBar, Inc. Common Stock
CWBR
$1K ﹤0.01%
263
-1
-0.4% -$5
AVID
3983
DELISTED
Avid Technology Inc
AVID
$1K ﹤0.01%
63
+53
+530% +$1.38K
TCRR
3984
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$1K ﹤0.01%
700
BSMX
3985
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$1K ﹤0.01%
200
PRTY
3986
DELISTED
Party City Holdco Inc.
PRTY
$1K ﹤0.01%
484
ECOM
3987
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$1K ﹤0.01%
+25
New +$433
LOGC
3988
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$1K ﹤0.01%
2,000
BLPH
3989
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$1K ﹤0.01%
1,221
OZON
3990
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$1K ﹤0.01%
90
AAXJ icon
3991
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.58B
-990
Closed -$69K
AKO.B icon
3992
Embotelladora Andina Series B
AKO.B
$4.69B
$0 ﹤0.01%
2
AMPY icon
3993
Amplify Energy
AMPY
$152M
-271
Closed -$2K
AMRX icon
3994
Amneal Pharmaceuticals
AMRX
$5.99B
$0 ﹤0.01%
118
-5,815
-98% -$16.3K
ANGI icon
3995
Angi Inc
ANGI
$252M
-43
Closed -$2K
APVO icon
3996
Aptevo Therapeutics
APVO
$5.25M
0
ARKQ icon
3997
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.87B
-100
Closed -$5K
ASA
3998
ASA Gold and Precious Metals
ASA
$941M
$0 ﹤0.01%
21
AVAL icon
3999
Grupo Aval
AVAL
$5.79B
$0 ﹤0.01%
190
-1,242
-87% -$3.98K
AVEM icon
4000
Avantis Emerging Markets Equity ETF
AVEM
$24.9B
-1,955
Closed -$102K

Similar funds

US Bancorp's Q3 2022 Portfolio in Review

As of Q3 2022, US Bancorp held 4,340 positions worth $48.4B, down 6.1% from $51.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

US Bancorp's Q3 2022 filing shows 176 new, 1,269 increased, 1,824 reduced and 174 closed positions. Its largest new stake was Goldman Sachs Access Treasury 0-1 Year ETF: 30,834 shares worth $3.08M. The largest sale was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, an estimated $271M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.

  • US Bancorp's largest Q3 2022 buy was Goldman Sachs Access Treasury 0-1 Year ETF: 30,834 shares worth $3.08M.
  • US Bancorp added most to Vanguard FTSE Developed Markets ETF in Q3 2022, an estimated $241M increase.
  • US Bancorp's biggest Q3 2022 reduction was Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, cutting an estimated $271M.
  • US Bancorp fully exited PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES) in Q3 2022, selling an estimated $9.57M.
  • US Bancorp's ten largest holdings make up 30% of its $48.4B portfolio in Q3 2022.
  • US Bancorp opened 176 new positions and closed 174 in Q3 2022.
  • US Bancorp's portfolio value fell 6.1% quarter-over-quarter to $48.4B.

Based on US Bancorp's 13F filing for Q3 2022, filed 27 Oct 2022.